Literature DB >> 10470192

Tumour markers CEA and CA 15-3 as Prognostic factors in breast cancer--univariate and multivariate analysis.

F C Ebeling1, U M Schmitt, M Untch, D Nagel, A Fateh-Moghadam, P Stieber, D Seidel.   

Abstract

Tumour markers are putative prognostic indicators for patients with breast cancer, but have not been elevated independently by multivariate analysis in a large patient number. In 550 patients with breast cancer without known metastases the levels of the serum tumour markers CEA und CA 15-3 were determined preoperatively and during follow-up. The prognostic relevance of these markers for recurrence (n = 128/487) and death of disease (n = 55/550) was evaluated in relation to established prognostic factors. In univariate analysis tumour size, lymph nodes, histological grading, age, hormone receptors, preoperative value of CEA (cut-off 2 ng/mL) and CA 15-3 (cut-off 25 U/mL) and their decrease of more than 33% within seven months after operation were significant for relapse. The results for death of disease were similar except for age. In multivariate analysis tumour size, lymph nodes and decrease of CEA > 33% (p < 0.001) were independent prognostic factors for recurrence. For overall survival tumour size, lymph nodes, histological grading and preoperative levels of CEA > or = 2 ng/mL (p = 0.038) and of CA 15-3 > or = 25 U/mL (p = 0.007) were independent prognostic factors. Pre- and postoperative values of the tumour markers CEA und CA 15-3 are strong independent prognostic factors for relapse and survival in breast cancer patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470192

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  [Clinical utility of serous tumoural markers].

Authors:  A Martín Suárez; L Alonso Díaz; I Ordiz Alvarez; J Vázquez; F Vizoso Piñeiro
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

2.  Circulating Tumor Cells in Metastatic Breast Cancer: A Prognostic and Predictive Marker.

Authors:  Sayyed Farshid Moussavi-Harami; Kari B Wisinski; David J Beebe
Journal:  J Patient Cent Res Rev       Date:  2014

3.  Determination of the prognostic value of preoperative CA15-3 and CEA in predicting the prognosis of young patients with breast cancer.

Authors:  Xuan Li; Danian Dai; Bo Chen; Hailin Tang; Xiaoming Xie; Weidong Wei
Journal:  Oncol Lett       Date:  2018-07-17       Impact factor: 2.967

4.  Evaluation of tumor markers (HER-2/neu oncoprotein, CEA, and CA 15.3) in patients with locoregional breast cancer: prognostic value.

Authors:  Rafael Molina; Jose M Augé; Jose M Escudero; Xavier Filella; Gabriel Zanon; Jaume Pahisa; Blanca Farrus; Montserrat Muñoz; Martin Velasco
Journal:  Tumour Biol       Date:  2010-04-02

Review 5.  Clinically Meaningful Use of Blood Tumor Markers in Oncology.

Authors:  Stefan Holdenrieder; Lance Pagliaro; David Morgenstern; Farshid Dayyani
Journal:  Biomed Res Int       Date:  2016-11-30       Impact factor: 3.411

6.  Hookah smoking and cancer: carcinoembryonic antigen (CEA) levels in exclusive/ever hookah smokers.

Authors:  Khan Mohammad Sajid; Kamal Chaouachi; Rubaida Mahmood
Journal:  Harm Reduct J       Date:  2008-05-24

7.  Bone metastases from breast carcinoma: histopathological - radiological correlations and prognostic features.

Authors:  J J James; A J Evans; S E Pinder; E Gutteridge; K L Cheung; S Chan; J F R Robertson
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.